A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects
Clinical trial NCT03722823 · COMPLETED
Trial details
- NCT number
- NCT03722823
- Sponsor
- Seagen Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-10
- Primary completion
- 2019-05-07
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.